Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PD-1 ANTIBODY FORMULATION
Document Type and Number:
WIPO Patent Application WO/2018/027524
Kind Code:
A1
Abstract:
Provided herein are pharmaceutical formulations for anti-PD-1 antibodies.

More Like This:
JPH11501665INDUSTRIAL APPLICABILITY The use of TNF alpha antagonists for the treatment of neurogenic skin redness
WO/2014/022830HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS
WO/2009/040426IMMUNOLIPOSOMES FOR TREATMENT OF CANCER
Inventors:
CAO WEI (US)
LI JUNFENG (US)
LIU XIAOLIN (US)
Application Number:
PCT/CN2016/094094
Publication Date:
February 15, 2018
Filing Date:
August 09, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INNOVENT BIOLOGICS SUZHOU CO LTD (CN)
International Classes:
A61K39/395
Domestic Patent References:
WO2012135408A12012-10-04
WO2011110604A12011-09-15
WO2015031667A22015-03-05
WO2016070051A22016-05-06
WO2016092419A12016-06-16
WO2016044189A12016-03-24
Other References:
TOPALIAN, S. L. ET AL.: "Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 366, no. 26, 28 June 2012 (2012-06-28), pages 2443 - 2454, XP055098235
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: DISPLAY PANEL, METHODS OF FABRICATING AND REPAIRING THE SAME

Next Patent: CIRCUIT BREAKER HAVING SELF-LOCKING FUNCTION